Pituitary tumors in childhood

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 1, 2012, Pages 63-67

  Harrington, Molly H ^a   Casella, Samuel J ^a  

^a CHILDREN S HOSPITAL AT DARTMOUTH   (United States)

Author keywords

children; craniopharyngioma; pituitary adenoma; pituitary tumor; prolactinoma

Indexed keywords

ALPHA INTERFERON; BETA CATENIN; BLEOMYCIN; CABERGOLINE; DIAZOXIDE; HYPOPHYSIS HORMONE; METFORMIN; SECURIN; WNT PROTEIN;

CHILDHOOD CANCER; CRANIOPHARYNGIOMA; DIABETES INSIPIDUS; DISEASE SEVERITY; EMBRYOLOGY; GAMMA KNIFE RADIOSURGERY; GENE OVEREXPRESSION; GENETIC REGULATION; GROWTH DISORDER; HEADACHE; HORMONE RELEASE; HUMAN; HYPERINSULINISM; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PARKINSON DISEASE; PREOPERATIVE CARE; PROLACTINOMA; RARE DISEASE; RATHKE CLEFT CYST; REVIEW; SELLA TURCICA; SURGICAL APPROACH; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

CHILD; CHILD, PRESCHOOL; CRANIOPHARYNGIOMA; FEMALE; HUMANS; MALE; PITUITARY HORMONES; PITUITARY NEOPLASMS; PROLACTINOMA;

EID: 84655169670     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e32834ed6b9     Document Type: Review

References (56)

1. Schroeder JW, Vezina LG. Pediatric sellar and suprasellar lesions. Pediatr Radiol 2011; 41:287-298; quiz 404-405.
2. Steele CA, MacFarlane IA, Blair J, et al. Pituitary adenomas in childhood, adolescence and young adulthood: presentation, management, endocrine and metabolic outcomes. Eur J Endocrinol 2010; 163:515-522.
3. Muller HL, Gebhardt U, Schroder S, et al. Analyses of treatment variables for patients with childhood craniopharyngioma: results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of followup. Horm Res Paediatr 2010; 73:175-180.
4. Hamilton JK, Conwell LS, Syme C, et al. Hypothalamic obesity following craniopharyngioma surgery; results of a pilot trial of combined diazoxide and metformin therapy. Int J Pediatr Endocrinol 2011; 2011:1-7.
5. Lek N, Prentice P, Williams R, et al. Risk factors for obesity in childhood survivors of suprasellar brain tumours: a retrospective study. Acta Paediatr 2010; 99:1522-1526.
6. Roth CL, Gebhardt U, Muller HL. Appetite-regulating hormone changes in patients with craniopharyngioma. Obesity (Silver Spring) 2011; 19:36-42.
7. Sahakitrungruang T, Klomchan T, Supornsilchai V, Wacharasindhu S. Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma. Eur J Pediatr 2011; 170:763-769.
8. Yang I, Sughrue M, Rutkowski M, et al. Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus 2010; 28:E5, p 1-11.
9. Delman BN. Imaging of pediatric pituitary abnormalities. Endocrinol Metab Clin North Am 2009; 38:673-698.
10. Muller HL. Childhood craniopharyngioma: current concepts in diagnosis, therapy and follow-up. Nat Rev Endocrinol 2010; 6:609-618.
11. Muller HL. Childhood craniopharyngioma: current controversies on management in diagnostics, treatment and follow-up. Expert Rev Neurother 2010; 10:515-524.
12. Colao A, Loche S. Prolactinomas in children and adolescents. Pediatr Neuroendocrinol 2010; 17:146-159.
13. Tarapore P, Sughrue M, Blevins L, et al. Microscopic endonasal transsphenoidal pituitary adenomectomy in the pediatric population. J Neurosurg Pediatr 2011; 7:501-509.
14. Fideleff HL, Boquete HR, Suarez MG, Azaretzky M. Prolactinoma in children and adolescents. Horm Res 2009; 72:197-205.
15. Ohmori K, Collins J, Fukushima T. Craniopharyngiomas in children. Pediatr Neurosurg 2007; 43:265-278. (Pubitemid 47056594)
16. Acharya SV, Gopal R, Bandgar T, et al. Clinical profile and long term follow up of children and adolescents with prolactinomas. Pituitary 2009; 12:186-189.
17. Colao A, Loche S. Prolactinomas in children and adolescents. Endocr Dev 2010; 17:146-159.
18. Muller HL. Childhood craniopharyngioma: recent advances in diagnosis, treatment and follow up. Horm Res 2008; 69:193-202. (Pubitemid 351562907)
19. Freda PU, Beckers AM, Katznelson L, et al. Pituitary incidentaloma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:894-904.
20. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms and disease. Dev Cell 2009; 17:9-26.
21. Gaston-Massuet C, Andoniadou CL, Signore M, et al. From the cover: increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci U S A 2011; 108:11482-11487.
22. Burdman JA, P.M, Heredia Serona GM, Bordon AE. Estrogen receptors in human pituitary tumors. Horm Metab Res 2008; 40:524-527.
23. Stratakis CA, Tichomirowa M, Boikos S, et al. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clin Genet 2010; 78:457-463.
24. Leontiou CA, The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 2008; 93:2390-2401. (Pubitemid 351831563)
25. Daly AF, Tichimirowa MA, Petrossians P, et al. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab 2010; 95:E373-E383.
26. Jaffrain-Rea ML, Angelini M, Gargano D, et al. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. Endocr Relat Cancer 2009; 16:1029-1043.
27. Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:273-288.
28. Kharlip J, Salvatori R, Yenokyan G, Wand GS. Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy. J Clin Endocrinol Metab 2009; 94:2428-2436.
29. Locatelli D, Massimi L, Rigante M, et al. Endoscopic endonasal transsphenoidal surgery for sellar tumors in children. Int J Pediatr Otorhinolaryngol 2010; 74:1298-1302.
30. Yamada S, Fukuhara N, Oyama K, et al. Surgical outcome in 90 patients with craniopharyngioma: an evaluation of transsphenoidal surgery. World Neurosurg 2010; 74 (2-3):320-330.
31. Jane JA Jr, Prevedello DM, Alden TD, et al. The transsphenoidal resection of pediatric craniopharyngiomas: a case series. J Neurosurg Pediatr 2010; 5:49-60.
32. Winkfield KM, Tsai HK, Yao X, et al. Long-term clinical outcomes following treatment of childhood craniopharyngioma. Pediatr Blood Cancer 2011; 56:1120-1126.
33. Kiehna EN, Merchant TE. Radiation therapy for pediatric craniopharyngioma. Neurosurg Focus 2010; 28:E10, p 1-7.
34. Smee RI, Williams JR, Kwok B, et al. Modern radiotherapy approaches in the management of craniopharyngiomas. J Clin Neurosci 2011; 18:613-617.
35. Sughrue ME, Yang I, Kane A, et al. Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma. J Neurooncol 2011; 101:463-476.
36. Liu AK, Bagrosky B, Fenton LZ, et al. Vascular abnormalities in pediatric craniopharyngioma patients treated with radiation therapy. Pediatr Blood Cancer 2009; 52:227-230.
37. Cavalheiro S, Di Rocco C, Valenzuela S, et al. Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha - a multicenter preliminary study with 60 cases. Neurosurg Focus 2010; 28:E12, p 1-7.
38. Muller HL, Albanese A, Calaminus G, et al. Consensus and perspectives on treatment strategies in childhood craniopharyngioma: results of a meeting of the Craniopharyngioma Study Group (SIOP), Genova 2004. J Clin Endocrinol Metab 2006; 19:453-454.
39. Kalina M, Skala-Zamorowska E, Kalina-Faska B, et al. Practical approach to childhood craniopharyngioma: a role of an endocrinologist and a general paediatrician. Childs Nerv Syst 2009; 25:1053-1060.
40. Garre ML, Cama A. Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr Opin Pediatr 2007; 19:471-479. (Pubitemid 47075630)
41. Ondruch A, Maryniak A, Kropiwnicki T, et al. Cognitive and social functioning in children and adolescents after the removal of craniopharyngioma. Childs Nerv Syst 2011; 27:391-397.
42. Muller HL. Consequences of craniopharyngioma surgery in children. J Clin Endocrinol Metab 2011; 96:1981-1991.
43. Zada G, Laws ER. Surgical management of craniopharyngiomas in the pediatric population. Horm Res Paediatr 2010; 74:62-66.
44. Iwayama H, Kamijo T, Ueda N. Hyperinsulinemia may promote growth without GH in children after resection of suprasellar tumors. Endocrine 2011; 40:130-133.
45. Roth CL, Blevins JE, Ralston M, et al. A novel rodent model that mimics the metabolic sequelae of obese craniopharyngioma patients. Pediatr Res 2011; 69:230-236.
46. Song-tao Q, Jun P, Yun-tao L, et al. The impact of the site of origin and rate of tumour growth on clinical outcome in children with craniopharyngiomas. Clin Endocrinol (Oxf) 2011.
47. Crowley RK, Hamnvik OP, O'Sullivan EP, et al. Morbidity and mortality in patients with craniopharyngioma after surgery. Clin Endocrinol (Oxf) 2010; 73:516-521.
48. Rottembourg D, O'Gorman CS, Urbach S, et al. Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma. J Pediatr Endocrinol Metab 2009; 22:867-872.
49. O'Gorman CS, Simoneau-Roy J, Pencharz P, et al. Sleep-disordered breathing is increased in obese adolescents with craniopharyngioma compared with obese controls. J Clin Endocrinol Metab 2010; 95:2211-2218.
50. Elliott RE, Sands SA, Strom RG, Wisoff JH. Craniopharyngioma Clinical Status Scale: a standardized metric of preoperative function and posttreatment outcome. Neurosurg Focus 2010; 28:E2.
51. Mortini P, Losa M, Pozzobon G, et al. Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg 2011; 114:1350-1359.
52. Jang YJ, Lee KS, Son BC, et al. Repeat operations in pediatric patients with recurrent craniopharyngiomas. Pediatr Neurosurg 2009; 45:451-55.
53. Visser J, Hukin J, Sargent M, et al. Late mortality in pediatric patients with craniopharyngioma. J Neurooncol 2010; 100:105-111.
54. Steno J, Bizik I, Steno A, Matejcik V. Craniopharyngiomas in children: how radical should the surgeon be? Childs Nerv Syst 2011; 27:41-54.
55. Rohrer T, Langer T, Grabenbauer G, et al. Growth hormone therapy and the risk of tumor recurrence after brain tumor treatment in children. J Pediatr Endocrinol Metab 2010; 23:935-942.
56. Kawamata T, Amano K, Aihara Y, et al. Optimal treatment strategy for craniopharyngioms based on long-term functional outcomes of recent and past treatment modalities. Neurosurg Focus 2010; 33:71-81.